Patients aged 6 to 11 years with cystic fibrosis receiving 24-week once-daily vanzacaftor/tezacaftor/deutivacaftor generally ...

I spent my childhood and young adulthood being told I was “too young and healthy” to be dealing with the health issues I experienced. But as an adult, I was determined to find answers, and eventually, ...

Researchers found frequent reports of infective pulmonary exacerbation among ... world studies to establish benefits in people with cystic fibrosis with these variants,” Keating and colleagues ...

Cystic fibrosis (CF) is a life-threatening genetic disease affecting ... While advancements like Trikafta have significantly ...

Before he could help countless patients battle cystic fibrosis over a decades-long medical career, H. Joel Schmidt had to ...

The commitment of organizations like the Cystic Fibrosis Foundation to global research funding and access initiatives has further propelled market growth. Additionally, major pharmaceutical companies, ...